These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 9083625)
1. Advanced fluorocarbon-based systems for oxygen and drug delivery, and diagnosis. Riess JG; Krafft MP Artif Cells Blood Substit Immobil Biotechnol; 1997; 25(1-2):43-52. PubMed ID: 9083625 [TBL] [Abstract][Full Text] [Related]
2. Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research. Krafft MP Adv Drug Deliv Rev; 2001 Apr; 47(2-3):209-28. PubMed ID: 11311993 [TBL] [Abstract][Full Text] [Related]
3. Fluorinated materials for in vivo oxygen transport (blood substitutes), diagnosis and drug delivery. Riess JG; Krafft MP Biomaterials; 1998 Aug; 19(16):1529-39. PubMed ID: 9794531 [TBL] [Abstract][Full Text] [Related]
4. Highly fluorinated amphiphiles and colloidal systems, and their applications in the biomedical field. A contribution. Krafft MP; Riess JG Biochimie; 1998; 80(5-6):489-514. PubMed ID: 9782389 [TBL] [Abstract][Full Text] [Related]
5. Overview of progress in the fluorocarbon approach to in vivo oxygen delivery. Riess JG Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):183-202. PubMed ID: 1391434 [TBL] [Abstract][Full Text] [Related]
8. The design and development of improved fluorocarbon-based products for use in medicine and biology. Riess JG Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(2):215-34. PubMed ID: 8087244 [TBL] [Abstract][Full Text] [Related]
9. Fluorocarbon-based in vivo oxygen transport and delivery systems. Riess JG Vox Sang; 1991; 61(4):225-39. PubMed ID: 1776239 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of cytotoxicity of new semi-fluorinated amphiphiles derived from dimorpholinophosphate. Courrier HM; Krafft MP; Butz N; Porté C; Frossard N; Rémy-Kristensen A; Mély Y; Pons F; Vandamme TF Biomaterials; 2003 Feb; 24(4):689-96. PubMed ID: 12437963 [TBL] [Abstract][Full Text] [Related]
11. [Current research on oxygen carriers for transfusion: hemoglobin solutions and fluorocarbon emulsions]. Labrude P Ann Pharm Fr; 1992; 50(5-6):250-66. PubMed ID: 1307671 [TBL] [Abstract][Full Text] [Related]
14. Development of highly fluid, concentrated and stable fluorocarbon emulsions for diagnosis and therapy. Riess JG; Dalfors JL; Hanna GK; Klein DH; Krafft MP; Pelura TJ; Schutt EG Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):839-42. PubMed ID: 1391519 [TBL] [Abstract][Full Text] [Related]
15. [Toward a second generation of fluorocarbon emulsions. Methodologies: synthesis of fluorocarbons, formulation, preparation and control of emulsions]. Leblanc M Rev Fr Transfus Immunohematol; 1986 Dec; 29(6):465-83. PubMed ID: 3296111 [TBL] [Abstract][Full Text] [Related]
16. Microemulsions of perfluorinated and semi-fluorinated compounds. Lattes A; Rico-Lattes I Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1007-18. PubMed ID: 7849905 [TBL] [Abstract][Full Text] [Related]
17. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Riess JG Artif Cells Blood Substit Immobil Biotechnol; 2005; 33(1):47-63. PubMed ID: 15768565 [TBL] [Abstract][Full Text] [Related]
18. Stability and stabilization of fluorocarbon emulsions destined for injection. Riess JG; Postel M Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):819-30. PubMed ID: 1391516 [TBL] [Abstract][Full Text] [Related]